BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) reported topline results from its Phase 2 ADDRESS-LC trial evaluating bezisterim, an oral investigational drug for Long COVID, showing statistically significant ...

“In healthcare communications, memorability is what helps turn awareness into action,” Pooja Bhavsar, SVP, strategic planner at The Bloc, said in a statement. “Make the Call was designed to be ...

Statistically significant benefits observed in bezisterim-treated Long COVID patients in pre-specified subgroups with high baseline fatigue, ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

An international clinical trial has identified a medication that can help prevent symptomatic COVID-19 in people exposed within households. The results could be particularly important for families ...

Controversy has emerged over allegations that Genencell, a pharmaceutical company accused of receiving Phase 2 clinical trial ...

Learn what to know about the 2026-2027 COVID vaccine, including XFG targeting, who is eligible, possible side effects, and ...

The Financial Supervisory Service (FSS) concluded in a report investigating pharmaceutical company Genencell’s COVID-19 new ...

Advanced respiratory support during acute hospitalization demonstrated the strongest pooled association with post-COVID-19 ...

Researchers have identified a potential treatment for the respiratory symptoms of long COVID after discovering an unknown cause of the condition inside the lungs. University of Virginia School of ...

Receipt of updated or booster COVID-19 vaccines reduced hospitalization and death among high-risk patients with autoimmune rheumatic diseases.